| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.09 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.09 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.077 | 0.09 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.086 | 0.09 |